Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacy-based Opportunistic Screening for Atrial Fibrillation Using a Portable ECG Device Integrated With Emergency Medical Services: a Prospective Type-1 Hybrid Implementation Study (NUMAPLUS Project)

NCT07598903 is registered in ClinicalTrials.gov with Centro de Emergencias Sanitarias 061 Andalucía as lead sponsor.

NCT NCT07598903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07598903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacy-based Opportunistic Screening for Atrial Fibrillation Using a Portable ECG Device Integrated With Emergency Medical Services: a Prospective Type-1 Hybrid Implementation Study (NUMAPLUS Project)
Lead sponsor
Centro de Emergencias Sanitarias 061 Andalucía
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 31, 2026
Enrollment
380 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrythmia, cardiac, atrial fibrillation (prevention of stroke), mass screening, pharmacies